Answers are grounded in this paper and cite their sources.
ctDNA analysis enables detection of MRD and predicts relapse after definitive treatment for solid cancers, thereby promising to revolutionize personalization of adjuvant and consolidation therapies.
No takes yet. Share an insight, caveat, or question.
Moding et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: